Monographie - Amoxicillin sodium / clavulanic acid

Ostatnia aktualizacja :
29/10/2024

Amoxicillin sodium / clavulanic acid

Struktura chemiczna

Nazwa handlowa

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Aktil	Węgry
Amoclan	Arabia Saudyjska
Amoklavin	Turcja
Amoksiklav	Polska
Amoxclav	Arabia Saudyjska
Amplamox	Brazylia
Augmentin	Arabia Saudyjska, Austria, Belgia, Chile, Ekwador, Francja , Grecja, Hiszpania, Holandia, Polska, Szwajcaria, Turcja, Wielka Brytania, Włochy, Zjednoczone Emiraty Arabskie
Betamox	Portugalia
Clavamox	Austria
Clavicin	Malezja, Wenezuela
Clavulin	Brazylia
Co-amoxi	Szwajcaria
Co-Amoxicillin	Szwajcaria
Curam	Arabia Saudyjska, nowa Zelandia
Darzitil	Argentyna
Dibional	Argentyna
Julmentin	Zjednoczone Emiraty Arabskie
Novamox	Brazylia
Sulbamox	Chile
Tarometin	Polska
Trifamox	Argentyna, Ekwador, KolumbiaKolumbia, Meksyk

Bibliografia : Amoxicillin sodium / clavulanic acid

	typ	publikacja
186	Czasopismo	Swart EL, Mooren RAG, Van Loenen AC. Compatibility of midazolam hydrochloride and lorazepam with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1995 ; 52: 2020-2022.
889	Czasopismo	Janknegt R, Stratermans T, Cilissen J, Lohman JJHM, Hooymans PM. Ofloxacin intravenous. Compatibility with other antibacterial agents. Pharm Weekbl [Sci] 1991 ; 13: 207-209.
1318	Czasopismo	Ashwin J, Lynn B, Taskis CB. Stability and administration of intravenous Augmentin. Pharm J 1987 ; 238: 116-118.
1357	Czasopismo	Janknegt R, Schrouff GGM, Hooymans PM, Hermens WJHH, Lohman JJHM. Quinolones and penicillins incompatibility. Ann Pharmacotherapy 1989 ; 23: 91-92.
1746	Czasopismo	Kambia N, Merite N, Dine T, Dupin-Spriet T, Gressier B, Luyckx M, Watinne C, Brunet C. Stability studies of amoxicillin/clavulanic acid combinaison in polyolefin infusion bags. EJHP 2010 ; 16, 30-37.
2139	Czasopismo	Serrurier C, Chenot ED, Vigneron J, May I, Demor? B. Assessment of injectable drug’s administration in two intensive care units and determination of potential physico-chemical incompatibilities. EJHP Science 2006 ; 12,5: 96-99.
2231	Czasopismo	de Jongh R, Hens R, Basma V, mouton JW, Tulkens PM, Carryn S. Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection. J Antimicrob Chemother 2008 ; 61, 2: 382-388.
3520	Laboratorium	Cidomycin - Summary of product Chracteristics. Sanofi 2011
3529	Laboratorium	Ciprofloxacin – Summary of Product Characteristics Hospira 2013
3545	Laboratorium	Amoxicilline / acide clavulanique - Résumé des caractéristiques du produit Mylan SAS 2009
3549	Laboratorium	Amikacine B Braun - Résumé des caractéristiques du produit. B Braun 2012
3643	Laboratorium	Gentamicin sulphate (Cidomycin®) - Summary of Product Characteristics Sanofi 2015
3674	Laboratorium	Erythromycin lactobionate - Summary of Product Characteristics PanPharma 2016
3791	plakat	Sadou Yaye H, Burtet E, Hamel C, Aljhni R, Gard C, Tilleul P. Étude de la compatibilité physico-chimique du phloroglucinol injectable durant les mélanges au sein des tubulures en Y. Apifh Congress, Paris November 2014 2014
3824	Czasopismo	Boudi S, Roy H, Forest JM, Leclair G. Compatibilité physique de l'association amoxicilline-acide clavulanique en injection avec plusieurs autres médicaments lors d'une administration en Y. Pharmactuel 2023 2023;56,3:91-98
3948	Czasopismo	Bouchoud L, Fonzo-Christe C, Klingm?ller M, Bonnabry P . Compatibility of Intravenous Medications With Parenteral Nutrition - In Vitro Evaluation. JPEN 2012 ;30. 416?424.
4470	Czasopismo	Claeysoone K, Basma V, Hens R, Van Bambeke F, de Jongh R, Tulkens P. Continuous versus intermittent infusion of temocillin in intensive care unit patient. Critical care 2005 ; 9(Suppl 1) P37
4524	plakat	Stucki C, Sautter A-M, Bonnabry P. Physical compatibility of the propofol emulsion with 33 drugs used in anaesthesiology. ESCP Symposium, Geneva, Switzerland 2009
4654	plakat	Sicard G, Donnette M, Martin N, Gensollen S, Pourroy B, Fanciullino R. Compatibilité visuelle du Vyxeos® lors d'administration en Y avec une sélection de médicaments injectables. Communication personnelle 2021

Mentions Légales